A federal judge in Maine has put the brakes on a pilot program that would have enabled biopharma companies to offer rebates instead of discounts as part of the 340B program beginning Jan. 1, 2026.

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its ...

Your liver cells are forgetting how to do their jobs under dietary stress. Here's how that signals cancer risk years before ...

When a professional sports owner steps into the world of hospital finance, the impact is usually symbolic. Rob Hale's latest move is anything but. The telecommunications executive and minority owner ...

You can live for years with obstructive sleep apnea and never know it. The condition repeatedly narrows your upper airway ...

When we think of healthcare, certain images come to mind: nurses at the bedside, doctors making diagnoses, or a surgeon in ...

Since February this year, a quiet but significant breakthrough unfolded in several of Beijing’s top neurosurgical hospitals. Working ...

What began as a battlefield partnership became a deep friendship, as an American veteran worked for years to help an Afghan interpreter enter the U.S. Just when it seemed they succeeded, the Trump ...

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

Tucked between rolling hills where the Ohio and Little Kanawha Rivers meet, Parkersburg, West Virginia stands as a hidden treasure for retirees seeking maximum lifestyle with minimum financial strain.